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a b s t r a c t
Mycobacterium tuberculosis (Mtb) has evolved protective and detoxiﬁcation mechanisms to maintain
cytoplasmic redox balance in response to exogenous oxidative stress encountered inside host phago-
cytes. In contrast, little is known about the dynamic response of this pathogen to endogenous oxidative
stress generated within Mtb. Using a noninvasive and speciﬁc biosensor of cytoplasmic redox state of
Mtb, we for ﬁrst time discovered a surprisingly high sensitivity of this pathogen to perturbation in redox
homeostasis induced by elevated endogenous reactive oxygen species (ROS). We synthesized a series of
hydroquinone-based small molecule ROS generators and found that ATD-3169 permeated mycobacteria
to reliably enhance endogenous ROS including superoxide radicals. When Mtb strains including
multidrug-resistant (MDR) and extensively drug-resistant (XDR) patient isolates were exposed to this
compound, a dose-dependent, long-lasting, and irreversible oxidative shift in intramycobacterial redox
potential was detected. Dynamic redox potential measurements revealed that Mtb had diminished
capacity to restore cytoplasmic redox balance in comparison with Mycobacterium smegmatis (Msm), a
fast growing nonpathogenic mycobacterial species. Accordingly, Mtb strains were extremely susceptible
to inhibition by ATD-3169 but notMsm, suggesting a functional linkage between dynamic redox changes
and survival. Microarray analysis showed major realignment of pathways involved in redox homeostasis,
central metabolism, DNA repair, and cell wall lipid biosynthesis in response to ATD-3169, all consistent
with enhanced endogenous ROS contributing to lethality induced by this compound. This work provides
empirical evidence that the cytoplasmic redox poise of Mtb is uniquely sensitive to manipulation in
steady-state endogenous ROS levels, thus revealing the importance of targeting intramycobacterial redox
metabolism for controlling TB infection.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Introduction
Reactive oxygen species (ROS) and reactive nitrogen species
(RNS) produced by the host enzymes are critical for controlling
Mycobacterium tuberculosis, the causative agent of tuberculosis
[1–3]. Moreover, both clinical observations in patients suffering
from chronic granulomatous disease and recent experimental
studies in zebra ﬁsh indicate a major role of superoxide (O2)
generated by NOX2 in neutrophil-mediated containment of myco-
bacterial infection in vivo [4,5]. Collectively, these studies suggest a
beneﬁcial role of host-generated ROS and RNS in limiting survival of
Mtb during infection. Despite the toxic effects of ROS and RNS, Mtb
survives and persists within macrophages, indicating that Mtb has
defense mechanisms to effectively counter host-generated exogen-
ous oxidative stress. In line with this, several studies have reported
the essential role of cell wall-associated lipids (cycloproponated
mycolic acids, PDIM, etc.) [6,7], secretory antioxidant enzymes
(superoxide dismutase [SodA, SodC], catalase [KatG], etc.), and
secretory redox buffer ergothionine (ERG) in providing an excellent
anatomical barrier to and detoxiﬁcation of exogenous oxidants [8].
Additionally, Mtb produces cytosolic reducing buffers such as
mycothiol (MSH) and thioredoxins (Trxs) to protect the cytoplasmic
redox environment from oxidative insult. However, while lack of
antioxidant secretion and cell wall lipid components adversely
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affect survival of Mtb in vivo [9,10], disruption of the cytoplasmic
redox systems MSH or Trxs does not attenuate Mtb replication
in vivo [11]. These ﬁndings indicate that cell surface-associated
mechanisms (e.g., SodA, KatG, mycolic acids) are necessary and
sufﬁcient to alleviate toxicity mediated by exogenous ROS and these
mycobacterial adaptive mechanisms seem to be important for
maintaining intrabacterial redox balance and persistence of Mtb
during infection. A modest increase in the endogenous O2 levels is
known to substantially damage DNA, proteins, and lipids in diverse
bacteria [12,13], indicating that in the case of Mtb infection, host-
generated O2 are effectively countered by mycobacterial protec-
tive systems to prevent overwhelming ampliﬁcation of endogenous
oxidants in Mtb which exceeds the organism's detoxiﬁcation and
repair capabilities. To gain a direct insight into this mechanism, we
have recently developed an elegant tool (Mrx1–roGFP2) to precisely
measure dynamic changes in the mycothiol redox potential (EMSH)
of Mtb during infection. Using this bioprobe, we demonstrated
transient oxidative changes in the EMSH of Mtb inside macrophages
[14], which concurs with the natural tolerance of Mtb toward
oxidative stress in phagocytes. Together, these ﬁndings indicate
that Mtb is genetically evolved to dissipate extracellular oxidative
stress encountered during infection.
Because of the robust mechanisms mitigating extracellular oxida-
tive stress, howMtb responds to speciﬁc elevation in endogenous ROS
levels has never been studied. Intriguingly, recent studies indirectly
indicate that Mtb might be sensitive to increases in endogenous ROS
levels. For example, rifampicin, a known RNA polymerase inhibitor,
was found to enhance ROS including hydroxyl radicals in Mtb [15,16].
However, the mechanism by which rifampicin generate ROS is poorly
understood and thus its lethality cannot be attributed to ROS alone.
Similarly, clofazimine has been shown to act through induction of
oxidative stress due to elevated ROS [17]. Due to its ability to
intercalate DNA [18], this drug is not a reliable prototype to study
the speciﬁc effects of elevated ROS. Although the antimalarial drug
artemisinin that acts through induction of oxidative stress is itself not
a Mtb inhibitor, it has recently been reported that when covalently
linked with mycobactin, a siderophore which enhances cell perme-
ability, the resulting conjugate is a potent antimycobacterial agent [15].
However, the requirement for iron as a trigger for oxidative stress
induction by artemisinin as well as the presence of the iron-chelating
mycobactin complicates mechanistic interpretations regarding the
mycobactericidal role of ROS. Together, while these studies partly
provide evidence for the sensitivity of Mtb toward oxidative stress, a
clear understanding of how pathogens respond to endogenous ROS
generated within Mtb cells remained uncharacterized.
In order to better understand the effects of elevated ROS inMtb, we
decided to test the consequences of exposure of Mtb to a set of novel,
cell-permeable, reliable, and efﬁcient superoxide radical generators
(ATD series). Using multiple experimental approaches involving sensi-
tive chemical, enzymatic, genetic, and expression assays, we investi-
gated the potential of ATD compounds in (i) enhancing endogenous
mycobacterial ROS production and (ii) impairing intramycobacterial
redox homeostasis. The exceptional growth inhibitory activity shown
by ATD compounds against drug-susceptible and drug-resistant strains
of Mtb unambiguously demonstrates that intramycobacterial redox
state is exceptionally sensitive to endogenous oxidative stress. Our
mechanistic ﬁndings open up fresh avenues of redox research
pertaining to the development of ROS generating anti-TB drugs.
Materials and methods
Dihydroethidium assay for superoxide detection
Dihydroethidium (DHE) assay was used for superoxide detection
[19–21]. A stock solution of dihydroethidium (0.93 mg, 2.95 μmol) was
prepared in DMSO (295 μl) and stored in the dark at 20 1C until its
use. A stock solution of the compound (5 μl, 10 mM) and DHE (5 μl of
10 mM) were reacted in acetonitrile:phosphate buffer of pH 7.4 (1:1,
v/v, 100 mM, ﬁnal volume 100 μl) for 3 h at 37 1C. The reaction
mixture was diluted to 50 μM using acetonitrile:phosphate buffer of
pH 7.4 (1:1, v/v, to a ﬁnal volume of 1 ml). The reaction mixture was
ﬁltered (0.22 μm) and injected (25 μl) in an Agilent high performance
liquid chromatograph (HPLC) attached with a ﬂuorescence detector
(excitation at 356 nm; emission at 590 nm). The column used was a
Zorbax SB C-18 reversed-phase column (2504.6 mm, 5 μm), the
mobile phase was water:acetonitrile containing 0.1% triﬂuoroacetic
acid and a gradient starting with 90: 10%-0min, 90: 10 to 70: 30-
0–45min, 30:70 to 0: 100-45–50min, 0: 100-50–55min, 10: 90-
55–60min was used with a ﬂow rate of 0.5 ml/min. Under these
conditions literature reports indicate that if superoxide is produced, a
peak for 2-hydroxyethidium (2-OH-Eþ), which elutes at 28.6 min,
would be observed [19–21]. When other oxidative species are
generated ethidium (Eþ) would be formed. Again, according to
literature reports Eþ elutes at 29.5 min [19–21]. We independently
conﬁrmed the formation of 2-OH-Eþ and Eþ by mass spectrometry.
Intracellular superoxide detection
For intracellular superoxide detection [19–21], Mycobacterium
smegmatis (MC2155) was cultured in 5 ml of middle brook M7H9
medium (M7H9, with 10% albumin–dextrose–saline (ADS) supple-
ment) at 37 1C for 24 h. The cultured bacteria were centrifuged to
aspirate out the medium and resuspended to an OD 600 nm of
0.5 with fresh M7H9 medium. This bacterial solution was incubated
with 50 μM of each ATD compound and 50 μM dihydroethidium
independently for 30 min in the dark by covering the falcon tube in
an aluminum foil. The suspension was centrifuged to aspirate out
any excess of the compound and/or DHE in the medium. The
collected bacterial pellet was resuspended with acetonitrile and
the cells were lysed using a probe sonicator for 3 min on ice. The
cell lysate was then removed by centrifugation and the supernatant
acetonitrile was separated and stored at 20 1C before injecting in
HPLC. The HPLC method used was as described previously [19–21].
A similar protocol was followed for the detection of intracellular
superoxide generation by ATD-3169 in Mycobacterium bovis BCG.
Preparation of mycobacterial cells for EMSH measurements by ﬂow
cytometry
Mycobacterial strains were grown in Middlebrook 7H9 medium
(Difco) supplemented with 10% ADS, 0.2% glycerol, 0.05% Tween 80
treated with 10 mM NEM for 5 min at room temperature (RT)
followed by ﬁxation with 4% PFA for 15 min at RT. After washing
thrice with 1X phosphate buffer saline (PBS), bacilli were analyzed
using a BD FACS Verse Flow cytometer (BD Biosciences). The
biosensor response was measured by analyzing the ratio at a ﬁxed
emission (510 nm) after excitation at 405 and 488 nm. Data were
analyzed using the FACSuite software.
MIC assays
MIC was determined using a microplate Alamar blue assay
(MABA). The Alamar blue assay was performed in 96-well ﬂat
bottom plates. Mtb strains were cultured in 7H9-ADS medium and
grown till exponential phase (OD 600 nm 0.4). Approximately
1105 bacteria were taken per well in a total volume of 200 ml of
7H9-ADS medium. Wells containing no Mtb were the autoﬂuores-
cence control. Additional controls consisted of wells containing cells
and medium only. After 5 days of incubation at 37 1C, 20 ml of 10X
Alamar blue was added and plates were reincubated for 24 h. The
ﬂuorescence readings were then recorded. Fluorescence intensity
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was measured in a SpectraMax M3 plate reader (Molecular Device)
in top-reading mode with excitation at 530 nm and emission at
590 nm. Percentage inhibition was calculated based on the relative
ﬂuorescence units and the minimum concentration that resulted in
at least 90% inhibition was identiﬁed as MIC.
Checkerboard synergy assay
Checkerboard synergy assay was performed using Alamar blue
dye in a 96-well plate as described [22]. Synergy was deﬁned by
fractional inhibitory concentration index (FICI) values of 0.5, antag-
onism by FICI values of 4¼4.0, and no interaction by FICI values
from 0.5 to 4.0. The ΣFICs were calculated as follows: ΣFICI¼FIC
AþFIC B, where FIC A is the MIC of drug A in the combination/MIC
of drug A alone, and FIC B is the MIC of drug B in the combination/
MIC of drug B alone.
Other assay protocols, synthetic procedures, and characteriza-
tion data are available in the Supplemental Information.
Results
2,3-Dihydro-1,4,-naphthooquinone-based small molecules generate
ROS inside mycobacteria
To examine the response of Mtb toward endogenous oxidative
stress, our ﬁrst challenge was to synthesize cell-permeable redox-
oriented compounds that speciﬁcally enhance ROS levels within Mtb
cells. Our preliminary analysis recently demonstrated growth inhibi-
tory activity of ROS generators based on a 2,3-dihydro-1,4,-naphtho-
quinone scaffold against mycobacteria [23]. While these molecules
are believed to generate intrabacterial ROS [23], a direct proof for this
and the exact mechanism by which they perturb mycobacterial
redox physiology to exert antimycobacterial activity remain unchar-
acterized. To investigate this, we ﬁrst synthesized a new series of
ROS-generating compounds (ATD series) in 80–90% yield (Fig. 1A and
Table S1) and characterized by NMR (see SI Experimental proce-
dures). These compounds undergo enolization in buffer to produce a
hydroquinone which is known to react with oxygen to generate up to
2 mol of superoxide (Fig. 1B) [24]. Furthermore, after generation of
ROS, a naphthoquinone would be produced, which in turn can
produce ROS through redox cycling (Fig. 1B). Thus, we predict that
an ATD series of compounds can potentially target mycobacterium
redox homeostasis through (i) spontaneous generation of ROS by
directly reducing oxygen, and (ii) elevating intramycobacterial ROS
levels by undergoing redox cycling inside mycobacteria.
To examine both possibilities, we ﬁrst monitored the ability of
ATD compounds to generate O2 under ambient aerobic conditions
in buffer adjusted to pH 8.0 using a widely reported luminol-based
chemiluminescence assay [25]. Xanthine oxidase (XO), an enzyme
which oxidizes hypoxanthine (X) to produce O2 and other
oxidants, served as a positive control in our assays. As a negative
control, we have synthesized a closely related derivative of ATD
compounds (ATD-4110), which is a naphthoquinone and is there-
fore incapable of spontaneously producing O2 in buffer. The
compounds ATD-3169, ATD-4064, and ATD-4054 produced signiﬁ-
cantly higher levels of O2 as revealed by 2- to 15-fold increased
chemiluminescence as compared to positive control at 20 min
postincubation (Fig. 2A; also see Supplemental Information Fig. S1).
A time-dependent analysis demonstrated an initial increase in O2
production for 20 min followed by a gradual decline (Fig. 2A). Since
the main aim of this work is to induce intramycobacterial O2
generation by ATD compounds, we determined O2 production
using a well-established and freely cell-permeable O2 indicator,
dihydroethidium [26]. It has been shown that DHE speciﬁcally
reacts with O2 to release ﬂuorescent product 2-hydroxyethidium
(2-OH-Eþ), which can be conveniently detected by analytical
techniques such as HPLC, ﬂuorescence microscopy, etc. [26]. The
reaction of DHE with other oxidants produces ethidium (Eþ). We
ﬁrst conﬁrmed O2 generation in the buffer at pH 8.0 using DHE.
An HPLC spectrum of O2 reaction products clearly showed varying
levels of 2-OH-Eþ and Eþ generated by ROS generators (Fig. 2C). As
expected, peaks correspond to 2-OH-Eþ and Eþ were not detected
in buffer alone or in the case of compound ATD-4110 (Fig. 2C).
To evaluate if our ROS generators are capable of promoting O2
inside mycobacterial cells, we exposed Mycobacterium smegmatis to
ATD compounds and DHE and detected ﬂuorescent peaks by HPLC.
Since cell death induced by ATD compounds might also elevate
intracellular ROS levels, O2 generation was monitored at an early
time point (60 min). Further, to minimize the contribution of
extracellular O2 present in the culture medium, we thoroughly
washed components of 7H9 growth medium and performed
measurements on cells suspended in 1X PBS. As shown in Fig. 2D,
intramycobacterial O2 was generated by all of the ATD com-
pounds. Interestingly, ATD-4110 generated comparable levels of
intramycobacterial O2, thus validating the redox-cycling-based
mechanism of ROS production within Msm cells by these com-
pounds. Exogenous O2 cannot penetrate the cell membrane [27],
suggesting that ATD compounds are permeating into the cell
interior and promoting endogenous O2 production possibly by
catalyzing electron cycling with ﬂavin, Fe–S clusters, and oxygen
Fig. 1. (A) Structures of ATD series of compounds prepared in this study. (B) Mechanism of O2 radical generation from 2,3-dihydro-1,4,-naphthoquinones involves
enolization in buffer to a diolate, which spontaneously produces superoxide by reacting with oxygen to give a quinone which in turn is known to undergo bioreduction to
generate superoxide.
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[28]. In a separate experiment,Msm cells pretreated with DHE were
then exposed to ATD-3169 and we similarly found an increase in
2-OH-Eþ , supporting the capability of this compound to permeate
mycobacteria to enhance intracellular ROS levels (see Supplemental
Information Fig. S2).
Since O2 rapidly undergoes dismutation to H2O2 and molecular
oxygen (O2) either spontaneously or by superoxide dismutase (SOD)
[28], we next analyzed the ability of ATD compounds to generate
H2O2. We incubatedMsmwith 50 μM of compounds for 60 min and
H2O2 released in the extracellular medium was measured using a
well-established ﬂuorescence-based Amplex Red assay [29]. A
calibration curve was generated with varying concentrations of
H2O2 and the levels of extracellular H2O2 can be quantiﬁed by this
assay (Fig. S1). We observed that while all of the compounds
produce H2O2, ATD-3169 showed exceedingly greater levels of
H2O2 in 2 h (Fig. 2B). Furthermore, consistent with the O2 data,
time–kinetic analysis demonstrated an initial increase in H2O2
production reaching a maximum value at 2 h posttreatment,
followed by a steady decrease (Fig. 2B). The eventual decrease in
O2 and H2O2 levels is in line with our recent study demonstrating
the presence of an efﬁcient antioxidant buffer system (mycothiol;
MSH) to rapidly counterbalance oxidative stress in Msm [14]. Taken
together, we have successfully designed novel small molecules
capable of enhancing intracellular ROS in mycobacteria.
ROS generators modulate mycothiol redox balance in Msm
We have shown the generation of O2 in buffer and inside Msm
by ATD compounds using redox-active ﬂuorogenic dyes and HPLC.
Although important for detecting ROS in vitro, intracellular detection
of ROS by ﬂuorogenic dye-based disruptive technologies can intro-
duce oxidation artifacts during cell lysis, which prohibits dynamic
measurements in real time [30,31]. Therefore, to validate our in vitro
ﬁndings and to ﬁnd out if ATD compounds are efﬁcient in over-
whelming mycobacterial antioxidant capacity, we next exploited a
recently reported noninvasive tool to measure dynamic changes in
intramycobacterial oxidation–reduction state [14]. Actinomycetes
including mycobacteria produce millimolar concentrations of an
antioxidant, mycothiol, which serves as a major cytoplasmic buffer
that protects bacteria from oxidative stress [32]. Since oxidative
stress rapidly oxidizes reduced mycothiol (MSH) to oxidized
mycothiol (MSSM), the ratio of mycothiol redox couple (MSH/MSSM)
or mycothiol redox potential (EMSH) provides a direct indicator of
mycobacterial redox state [14]. To examine if the ROS generators
perturb mycobacterial redox balance, we ﬁrst performed dynamic
measurement EMSH of Msm in response to ATD compounds using
a highly sensitive and speciﬁc biosensor of intramycobacterial
mycothiol redox potential (EMSH; Mrx1–roGFP2) [14]. In Mrx1–
roGFP2, oxidation–reduction-sensitive GFP (roGFP2) is covalently
fused to Mtb mycothiol-speciﬁc oxidoreductase mycoredoxin-1
(Mrx-1), which reversibly transfers electrons between the mycothiol
redox buffer and the thiol groups of roGFP2 [14]. Therefore, con-
tinuous formation and release of the roGFP2 disulﬁde bridge are
coupled with the actual redox potential of the mycothiol buffer inside
mycobacteria [14]. The oxidation and reduction state of Mrx1–
roGFP2 thiols can be easily detected by measuring ﬂuorescence
intensity at 405 and 488 nm excitation wavelengths with a ﬁxed
emission wavelength of 510 nm [14]. Increase or decrease in Mrx1–
roGFP2 ratio (405/488) indicates oxidative or reductive shift in EMSH
of a mycobacterial cell, respectively [14].
Msm expressing Mrx1–roGFP2 biosensor was independently
exposed to various concentrations of ATD compounds (1.5 to 25 μM)
and two known ROS generators (H2O2 and cumene hydroperoxide
[CHP]). The ratiometric response was measured by ﬂow cytometry at
24 h posttreatment. Surprisingly, despite showing increased generation
of ROS inside Msm, most of the ATD compounds were ineffective in
increasing the Mrx1–roGFP2 ratio at each concentration tested, indicat-
ing an effective induction of mycothiol antioxidant system in response
to ROS generators (Fig. 3A). Similar results were obtainedwith H2O2 and
CHP treatment (Fig. 3A). Only treatment with 25 μM of ATD 3169 and
ATD 4064 induced signiﬁcant oxidative shift in EMSH ofMsm (Fig. 3A). To
examine if enhanced oxidative EMSH induced by ATD-3169 and ATD
4064 correlated with growth inhibition, we determined minimal
inhibitory concentrations (MICs) of these compounds against Msm
using MABA. Alamar blue (AB) is an oxidation–reduction indicator
dye that has been widely used to measure the sensitivity of mycobac-
teria to anti-TB drugs [33]. A change in nonﬂuorescent blue to
ﬂuorescent pink indicates reduction of AB due to growth, whereas
inhibition of growth by antimycobacterial compounds interferes with
AB reduction and color development. Consistent with theMrx1–roGFP2
ﬁndings, most of the ROS generators were inefﬁcient in inhibiting
growth of Msm even at concentrations higher than 200 μM (Table 1).
Importantly, ATD-3169 completely prevented Msm growth at a mini-
mum inhibitory concentration (MIC) of 50 μM, while lower oxidative
stress induced by ATD-4064 correlated with the higher MIC value
against Msm (200 μM, Table 1). It can be argued that the use of
Fig. 2. (A) The time course of superoxide radical anion (O2) generation during incubation in pH 8.0 buffer over 30 min was studied by a luminol chemiluminescence assay.
(Note: XþXO generates O2 rapidly, typically o1 min). (B) Time course of hydrogen peroxide (H2O2) generated during incubation of Wt-Msm with 10 mM of the compound
in pH 7.4 was estimated using an Amplex Red ﬂuorescence assay. (C) A HPLC-based dihydroethidium (DHE) assay was used to infer generation of O2 after incubation of
compounds (50 mM) in pH 8.0 buffer for 1 h. 2-Hydroxyethidium (2-OH-Eþ), which is exclusively formed by the reaction of O2 with DHE, elutes at 28.6, and ethidium Eþ ,
which is formed by nonspeciﬁc oxidation of DHE, elutes at 29.5 min. (D) HPLC traces of assay for intracellular O2production using a dihydroethidine (DHE) assay in
Mycobacterium smegmatis (Wt-Msm). Incubation with compounds (50 mM) was for 30 min and DHE levels indicate unoxidized dye while 2-OH-Eþ formed is an indicator for
O2 production and Eþ is indicative of increase in oxidative species.
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redox-cycling compounds can inﬂuence AB oxidation–reduction to
compromise the MABA assay. To address this issue, we validated the
inhibitory effect of a few ATD compounds (ATD 3169, ATD 4064, and
ATD 4110) onMsm by analyzing colony forming units (CFUs). As shown
in Fig. 3B, Msm treated with ATD compounds at MIC concentrations
displayed2.5 log reduction in CFUs as compared to untreated cells at
24 h posttreatment. These results conﬁrm that both MABA and CFU
analyses are in reasonable agreement with each other and that ATD
compounds exert bactericidal effects on mycobacterial cells.
A direct linkage between oxidative EMSH and growth inhibition
suggests that disruption of mycothiol redox homeostasis is the under-
lying mechanism by which ATD-3169 exerts an antimycobacterial
effect. However, ATD-3169 was ineffective in reducing Msm growth at
concentrations lower than 25 μM. We reasoned that this could be due
to efﬁcient recruitment of the mycothiol antioxidant system to
dissipate ROS generated by lower concentrations of ATD-3169. To
show this, we exposed Msm expressing Mrx1–roGFP2 to nontoxic
concentrations of ATD-3169 (3.1, 6.25, 12.5 μM) and the ratiometric
response was measured at early time points to capture dynamic
changes in EMSH. Addition of ATD-3169 resulted in a rapid increase in
Mrx1–roGFP2 ratio in a concentration-dependent manner (Fig. 3C). As
indicated in Fig. 3C, maximum oxidation induced by various concen-
trations of ATD-3169 was achieved within 15 min postexposure.
Interestingly, the observed increase in Mrx1–roGFP2 ratio was not
long lasting and cells recovered from the oxidative insult as indicated
by a decrease in 405/480 ratio to basal levels within 180min
posttreatment (Fig. 3C), indicating activation of an MSH-dependent
antioxidative mechanism. As a control, we have similarly tracked
changes in EMSH on treatment of Msm with a toxic concentration (i.e.,
50 μM) of ATD-3169. In this case, Msm displayed a sustained and
irreversible increase in 405/488 ratio, conﬁrming the role of over-
whelming mycothiol oxidation caused by higher concentrations of
ATD 3169 (Fig. 3C). Lastly, to conﬁrm the role of MSH in tolerating
oxidative stress generated by ATD-3169, wemeasured the MIC of ATD-
3169 against MSH-negative strains of Msm (MsmΔmshA and
MsmΔmshD). As shown in Tables 1, a 2-fold lower concentration of
ATD-3169 was sufﬁcient to inhibit growth of MSH-negative strains as
compared to wt Msm. Consistent with these ﬁndings, Amplex Red
assay showed that MsmΔmshA consistently displayed higher levels of
extracellular H2O2 as compared to wt Msm (Fig. 3D). These results
conﬁrmed that Msm responds to ATD compounds by inducing
dynamic changes in MSH redox signaling and homeostasis, and
suggest that efﬁcient generation of intrabacterial ROS may induce
killing by compromising reductive capabilities of mycobacteria.
ATD-3169 perturbs mycothiol redox homeostasis in Mtb
Several studies have indicated that slow growing mycobacteria,
includingMtb, lack protective oxidative stress responses due to the
absence of a functional copy of oxidative stress regulators such as
OxyR and SoxR [34]. Moreover, pathogenic and drug-resistant Mtb
strains displayed relatively oxidized steady-state intrabacterial
Fig. 3. ATD compounds induce an oxidative shift in EMSH of Msm. (A) Msm expressing Mrx1–roGFP2 was treated with various ATD series compounds, H2O2 and CHP (from
1.5–25 μM) for 24 h and the sensor response was measured by ﬂow cytometry by exciting at 405 and 488 nm lasers and constant emission at 510 nm. (B)Msm was grown to
an OD600 nm of 0.6, diluted to an OD600 nm of 0.06 and treated with ATD-3169 (50 mM), ATD-4064 (200 mM), ATD-4110 (200 mM) for 24 h. CFUs were plated at 0 and 24 h on
7H11 solid media supplemented with ADS. (C) Msm expressing Mrx1–roGFP2 was treated with nonlethal (3.1, 6.25, 12.5 μM) and lethal (50 mM) concentrations of ATD-3169,
and the sensor response was measured by ﬂow cytometry at various time points. Error bars represent standard deviations from the mean. Data shown are the representative
of at least three different experiments performed in triplicate. (D) The time course of H2O2 generated during incubation ofWt-Msm andMsmΔmshA strains with 10 mM of the
ATD-3169 compound in pH 7.4 was estimated using an Amplex Red ﬂuorescence assay.
Table 1
Minimal inhibitory concentrations (MICs) of ROS generators against diverse bacterial species.
Strain ATD-3167 ATD-3169 ATD-4053 ATD-4054 ATD-4064 ATD-4110
Staphylococcus aureus 4100 mM 4100 mM 4100 mM 4100 mM 4100 mM 4100 mM
E. coli 4100 mM 4100 mM 4100 mM 4100 mM 4100 mM 4100 mM
Salmonella typhimurium 4100 mM 4100 mM 4100 mM 4100 mM 4100 mM 4100 mM
Klebsiella pneumoniae 4100 mM 4100 mM 4100 mM 4100 mM 4100 mM 4100 mM
Pseudomonas aeruginosa 4100 mM 4100 mM 4100 mM 4100 mM 4100 mM 4100 mM
Msm mc2155 200 mM 50 mM 4200 mM 4200 mM 200 mM 4200 mM
H37Rv 100 mM 3.125 mM 100 mM 450 mM 12.5 mM 12.5 mM
MDR (Jal 2287) 50 mM 3.125 mM 25 mM 450 mM 6.25 mM 6.25 mM
XDR (Myc-431) 100 mM 6.25 mM 50 mM 450 mM 25 mM 25 mM
MDR (Jal 2261) ND 3.125 mM ND ND ND ND
MDR (Jal 1934) ND 3.125 mM ND ND ND ND
MDR (BND320) ND 3.125 mM ND ND ND ND
M. bovis BCG ND 3.125 mM ND ND ND ND
H37Rv ΔMshA ND 0.3125 mM ND ND ND ND
H37Rv ΔMshA comp ND 3.125 mM ND ND ND ND
MsmΔmshA ND 25 mM ND ND ND ND
MsmΔmshD ND 25 mM ND ND ND ND
MICs of ATD compounds against a range of Gram-positive and Gram-negative bacteria were measured using the microbroth dilution technique as recommended by National
Committee for Clinical Laboratory Standards. MIC, minimum inhibitory concentration; ND, not determined.
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EMSH as compared to nonpathogenic Msm, and exhibited excep-
tional sensitivity to endogenous increase in oxidant levels
[14,34,35]. On this basis, we hypothesized that Mtb strains might
show differential sensitivity toward ATD-3169 as compared to
Msm. To examine this possibility, we expressed Mrx1–roGFP2 in
the virulent laboratory strain (Mtb H37Rv), and two Indian patient
isolates of Mtb, i.e., a multidrug-resistant strain (Jal-2287) and an
extensively drug-resistant strain (MYC 431) [14].
Mtb strains expressing Mrx1–roGFP2 were exposed to lower
concentrations of ATD-3169 (3.1, 6.25, 12.5 μM) at which Msm
robustly maintained intrabacterial EMSH and survival. As a positive
control, we treated Mtb H37Rv with 1 mM H2O2. To minimize the
contribution of cell death in generating oxidative stress, we mea-
sured the Mrx1–roGFP2 ratio at early time points. Addition of ATD-
3169 rapidly increased the Mrx1–roGFP2 ratio in a concentration-
dependent manner among the Mtb strains (Fig. 4A, B, and C).
Similar oxidation of Mrx1–roGFP2 was detected on exogenous
exposure to H2O2 (Fig. 4D). However, while the Mrx1–roGFP2 ratio
gradually decreased to baseline values in the case of H2O2-chal-
lenged Mtb (Fig. 4D), ATD-3169-treated Mtb remained oxidatively
stressed throughout the course of the experiment (Fig. 4A). The
ratiometric ﬂuorescence pattern displayed by the drug-resistant
strains Jal 2287 and MYC 431 was comparable to that of Mtb H37Rv
(Fig. 4B and C). Since we have shown that ATD-3169 induces an
oxidative shift in EMSH of Msm by generating endogenous ROS such
as O2 via redox cycling, we asked if a similar mechanism exists for
Mtb. However, due to technical and biosafety challenges associated
with handling and processing a BSL3 class pathogen such asMtb for
HPLC analysis, we measured O2 levels inside a related but
nonpathogenic slow growing vaccine strain of mycobacteria, Myco-
bacterium bovis BCG. It has been previously reported that the
intrabacterial EMSH of BCG is similar to that of Mtb, indicating a
comparable cytoplasmic redox state of these two species under
normal growing conditions [14]. Moreover, BCG was found to be
equally sensitive to ATD-3169 as compared to Mtb strains (Table 1).
Using a DHE assay, we found that BCG cells treated with ATD-3169
generate peaks corresponding to O2 (2-OH-Eþ) and other ROS
(Eþ) (Fig. 4E). As a positive control, we used a well-known O2
generator (menadione) in our assay and similarly detected a 2-OH-
Eþ peak, conﬁrming the generation and detection of O2 by
menadione and ATD-3169 inside BCG (Fig. 4E). These results
indicate that ATD-3169 severely impaired the ability of Mtb to
orchestrate an efﬁcient and dynamic MSH-speciﬁc antioxidant
response by generating overwhelming endogenous oxidative stress.
Low concentrations of ATD-3169 efﬁciently inhibit growth of drug-
resistant Mtb strains
Having shown that ATD-3169 is efﬁcient in perturbing
mycothiol redox balance in Mtb strains, we next determined the
MIC of ATD-3169 against several virulent and drug-resistant
strains of Mtb using MABA assay. These include a laboratory strain
(Mtb H37Rv), and several clinical drug-resistant strains of Mtb, i.e.,
single drug-resistant (BND 320), multidrug-resistant (MDR- Jal
2261, 1934, Jal 2287), and extensively drug-resistant (XDR- MYC
431) [14]. In complete agreement with the Mrx1–roGFP2 ﬁndings,
virulent and drug-resistant clinical strains showed exceptional
sensitivity toward ATD-3169. A concentration range of 3.125–
6.25 mM was sufﬁcient to uniformly inhibit the growth of Mtb
strains (Table 1). The killing potential of ATD-3169 was also
conﬁrmed by enumerating colony-forming units (CFUs) of Mtb at
various time points posttreatment (Fig. 4F). Lastly, when tested
against human embryonic kidney cells HEK293, a cell viability
assay revealed no signiﬁcant inhibition at 25 mM [24]. Thus, at
concentrations where complete inhibition of Mtb was observed,
the compounds were well tolerated by mammalian cells. These
results suggest that the endogenous production of O2 and H2O2
by ATD-3169 effectively perturbed mycothiol redox balance to
speciﬁcally compromise growth of virulent and drug-resistant Mtb
strains.
Targeting mycothiol pathway increases sensitivity of Mtb to ATD-
3169
Earlier studies have shown that MSH-deﬁcient mycobacteria
are susceptible to broad classes of antibiotics [36,37]. Recently we
have shown that while anti-TB drugs do not alter EMSH of Mtb
during growth in culture medium, they speciﬁcally induce intra-
mycobacterial oxidative EMSH to exert efﬁcient mycobactericidal
activity during infection [14]. Collectively, these ﬁndings under-
score the importance of MSH-redox homeostatic mechanism(s) in
protecting mycobacteria against antibiotics. Contrary to known
anti-TB drugs, treatment with ATD-3169 produces ROS inside
mycobacteria and induces an intrabacterial oxidative shift in EMSH
of Mtb in culture medium in vitro. To decisively show that ATD-
3169 functions by disturbing mycothiol redox balance, we assessed
the effect of ATD-3169 on an Mtb H37Rv strain deﬁcient in
mycothiol biosynthesis (MtbΔmshA). The MtbΔmshA strain does
not produce mycothiol and showed sensitivity to oxidants [38,39].
We found that the MtbΔmshA strain was 10 times more sensitive
to ATD-3169 as compared to wt Mtb H37Rv (MIC 0.3125 μM)
(Table 1). Complementation ofMtbΔmshA with an integrated copy
of wt mshA restored the sensitivity to Mtb H37Rv levels. These
results suggest that the mycothiol system is one of the main
intrinsic mechanisms for protection against ATD-3169 in Mtb.
Similar to ATD-3169, another redox-cycling drug, clofazimine
(CFZ), has been shown to induce mycobacterial killing by generat-
ing ROS and inducing an oxidative shift in EMSH during growth in
culture medium [14]. Therefore, we checked if the CFZ and ATD-
3169 combination acts synergistically onMtb. First the MICs of CFZ
and ATD-3169 were determined independently using an AB assay
and found to be consistent with previously reported MIC values for
CFZ (Table 2). Second, using a checkerboard assay (see Experi-
mental procedures), compound interactions were determined by
growing Mtb strains in sub-MIC concentrations of CFZ and sub-
MIC fractions of ATD-3169. The ΣFIC (fractional inhibitory con-
centration) for each combination was calculated and given in
Table 2. The combination of CFZ and ATD-3169 gave a ΣFIC of
r0.5 against the drug-sensitive laboratory strain (H37Rv) and
drug-resistant clinical strains (Jal 2287 and MYC 431), indicating
that both drugs act synergistically and therefore affect similar
aspects of mycobacterial redox physiology. As a control, we
performed a checkerboard assay using an isoniazid (INH) and
ATD-3169 combination and found no synergy (data not shown),
thereby conﬁrming that the antimycobacterial activity of ATD-
3169 is linked to ROS generation and MSH redox imbalance. Taken
Table 2
Data showing synergy between ATD-3169 and clofazimine (CFZ).
Strain Drug combination MIC (mM for 3169, mg/ml
for clofazimine)
FIC FICI
Alone Combination
H37Rv 3169 3.125 0.7 0.23 0.47
Clofazimine 0.25 0.0625 0.24
Jal2287 (MDR) 3169 3.125 0.7 0.23 0.478
Clofazimine 0.125 o.031 0.248
Myc 431 (XDR) 3169 6.25 1.5 0.24 0.49
Clofazimine 0.5 0.125 0.25
Inﬂuence of ATD-3169 and CFZ combination against drug-sensitive (H37Rv),
multidrug resistant (MDR: Jal 2287), and extensively drug-resistant (XDR: Myc
431) strains of Mtb was examined using a checkerboard assay.
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together, our data for the ﬁrst time revealed that Mtb is uniquely
sensitive to elevation in endogenous ROS levels, and suggest
selective targeting of mycobacterial redox homeostasis by produ-
cing excessive oxidative stress within Mtb cells as a potential new
intervention strategy against TB.
ATD-3169 modulates expression of genes associated with the
antioxidant system, DNA repair, central metabolism, and cell wall
lipid biosynthesis
To further understand the mechanism of ATD-3169 action, we
performed microarray analysis ofMtb H37Rv exposed to 30 mM ATD-
3169 for 4 h (see SI Experimental procedures). A transcriptional
response showed differential regulation of 500 genes in response
to ATD-3169 (2-fold cutoff, Pr0.05, Table S2). Since ROS generally
damage DNA, proteins, and lipids, a transcriptional response to ATD-
3169 is largely composed of genes involved in DNA repair, cell wall
lipid biosynthesis, iron homeostasis, sulfur metabolism, redox-active
proteins, citric acid cycle proteins, and transcriptional regulators
(Fig. 5A and Table S2). Given that ATD-3169 induced substantial
oxidative stress, expression of katG was highly upregulated (35-
fold) on treatment. Additionally, several genes involved in the
oxidation–reduction reactions such as hpx (heme haloperoxidase),
Rv1786 (ferredoxin), oxidoreductases (Rv0068, Rv0149, Rv0183), and
monooxygenases (Rv0892, Rv3083, Rv1393c) were inﬂuenced by
ATD-3169 (Fig. 5B). Because DNA is one of the sensitive targets of
ROS, we expected to see many genes involved in DNA metabolism to
be differentially expressed in response to ATD-3169. Consistent with
this, among the highly upregulated genes were those which encode
for helicases (uvrC, uvrD), DNA repair and recombination (recA, radA,
dinP, alkB, nei, etc.), DNA supercoiling (gyrA, gyrB), SOS response
(lexA), etc. (Fig. 5C). The upregulation of several genes involved in cell
wall lipid/polyketide biosynthesis (mma3, mma2, pks2, pks7, papA1,
papA3, etc.) and fatty acid metabolism (fas, fadD9, fadD22, fadD31,
etc.) indicates damage of the cell wall lipid architecture by ATD-3169
(Fig. 5D). Since ATD-3169 inhibits growth of Mtb by perturbing
Fig. 4. ATD-3169 induces a long-lasting oxidative shift in EMSH of Mtb strains. Mtb strains (A) H37Rv, (B) Jal 2287, and (C) MYC 431 expressing Mrx1–roGFP2 were treated
with ATD-3169 at various concentrations and the sensor response was measured by ﬂow cytometry at various time points. Data shown are representative of at least three
different experiments performed in triplicate. (D) H37Rv expressing Mrx1–roGFP2 was treated with 1 mM H2O2 and the sensor response was measured by ﬂow cytometry as
a function of time. Data shown are representative of at least two different experiments performed in triplicate. Error bars represent standard deviations from the mean.
(E) HPLC traces of assay for intracellular O2 production using a dihydroethidine (DHE) assay in BCG. Incubation with compounds (50 mM) was for 30 min and DHE levels
indicate unoxidized dye while 2-OH-Eþ formed is an indicator for O2 production and Eþ is indicative of an increase in oxidative species. Menadione is a known redox-
cycling agent that enhances ROS and was used as a positive control. (F) H37Rv was grown to an OD600 nm of 0.6, diluted to an OD600 nm of 0.06, and treated with 3.1 μM ATD-
3169 compound. At the indicated time points, CFUs were determined by plating cultures on 7H11 solid media supplemented with ADS. *Po0.05 as compared to untreated
control day 0,þP o0.05 as compared to untreated control day 5.
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mycothiol redox homeostasis, we reasoned that pathways involved
in the biosynthesis of intracellular thiols might be affected by this
compound. In agreement with this, genes involved in the biosynth-
esis of reduced sulfur metabolites such as cysteine and methionine
[metH, cysN, cysD, sahH, etc.] and the prominent sulfur-containing
cell wall glycolipid, sulfolipid-1 (pks 2, papA1) were induced on
treatment (Fig. 5E).
Because iron homeostasis is intrinsically coupled to ROS-
mediated lethality [12,40], genes involved in iron storage (bfrB,
Rv2455c) and iron regulation (ideR, furA) were highly induced in
our expression data (Fig. 5F). The induction of iron-repressor and
iron-storage genes indicates the increase in free iron content on
treatment with ATD-3169, suggesting a possible leaching of iron
by endogenous O2 from iron-binding proteins such as Fe–S
Fig. 5. Global changes in the expression ofMtb H37Rv genes in response to ATD-3169.Mtb H37Rv was grown to an O.D600 nm of 0.4 and treated with 30 μM ATD-3169 for 4 h
at 37 1C. Total RNA was isolated and subjected to microarray analysis as noted under Materials and methods. (A) Pie chart corresponding to differentially expressed genes in
response to ATD-3169, functionally classiﬁed in 13 classes based on the annotation given in the tubercuList database. Differentially regulated genes were shown in the heat
maps. (B) Detoxiﬁcation, miscellaneous oxidoreductases, and oxygenases, (C) DNA replication, repair, recombination, and restriction/modiﬁcation, (D) fatty acid catabolism
and lipid anabolism, (E) sulfur metabolism, (F) transcriptional regulators, (G) TCA cycle and glyoxylate cycle genes, and (H) drug efﬂux pumps. (I) qRT-PCR validation of a
select number of genes differentially regulated in the microarray data. Data shown are the representative of at least two difference experiments performed in triplicate. Error
bars represents standard deviations from the mean.
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cluster proteins. In line with this, we observed overexpression of
csd, which encodes for a cysteine desulfurase involved in the
repair of oxidatively damaged Fe–S clusters [41]. One of the uniﬁed
mechanisms by which ROS inhibit growth of prokaryotic and
eukaryotic organisms is by releasing iron from the citric acid cycle
enzyme like [Fe–S]-dependent dehydratase, aconitase [28]. Inter-
estingly, we found that ATD-3169 induced expression of multiple
genes which encode for citric acid cycle enzymes including Fe–S
containing aconitase (acn), 2-oxoglutarate dehydrogenase (kgd),
and dihydrolipoamide dehydrogenase (Rv0794c), indicating a
direct role of endogenous ROS generated by ATD-3169 in inacti-
vating these mycobacterial enzymes (Fig. 5G). Additionally, genes
involved in glyoxylate cycle (isocitrate lyase; icl) and gluconeogen-
esis (phosphoenolpyruvate carboxykinase; pck), which counter-
balance oxidative stress by increasing the yield of reducing power
in mycobacteria [42,43], were found to be upregulated by ATD-
3169 (Fig. 5G). These results indicate a functional linkage between
energy metabolism and intracellular redox balance, and suggest a
major role of central metabolism in increasing the efﬁciency of
Mtb to tolerate oxidative stress.
Increased expression of multiple drug efﬂux pumps provides a
critical defense against redox-cycling drugs in Escherichia coli [44].
Similarly, induction of genes encoding efﬂux pumps, including
Rv2688c, Rv1410c, Rv2326c, phoY2, etc., indicates that Mtb tries to
reduce endogenous ROS levels by limiting intracellular accumula-
tion of ATD-3169 (Fig. 5H). Mtb's adaptive response to oxidative
stress is dependent on multiple transcriptional regulators and
stress-dependent sigma factors [8]. A large number of gene reg-
ulators including Rv3160c, Rv1474c, Rv3055, Rv0067c, Rv3050c, ideR,
furA, etc. were induced by ATD-3169 (Fig. 5F). Lastly, using quanti-
tative reverse-transcriptase PCR (qRT-PCR), we veriﬁed the micro-
array results by monitoring the differential expression of a select
number of Mtb genes in response to ATD-3169 (Fig. 5I; Table S2, SI).
In sum, data generated from multiple techniques clearly show that
the efﬁcient antimycobacterial activity shown by the ATD-3169 is a
consequence of increased intrabacterial oxidative stress and asso-
ciated damage to cellular pathways involved in ROS detoxiﬁcation,
and repair of essential metabolites such as DNA, proteins, and lipid
in Mtb.
Discussion
Increased emergence of drug-resistant Mtb strains coupled with a
meager number of new antibiotics in the pipeline has necessitated an
urgent need to enhance our portfolio of anti-TB drugs. In this context,
a paradigmatic approach would be to induce long-lasting and irrever-
sible changes in cellular homeostatic mechanisms of Mtb. Several
studies in humans, animal models, and macrophages clearly indicate
that exogenous oxidants such as O2 produced by a phagocytic
respiratory burst are critical components of host defense against
bacterial infection [3–5]. Furthermore, owing to exceptionally higher
rate constants (106 M1, s1) for O2-mediated inactivation of
essential metabolic enzymes such as dehydratase and mononuclear
enzymes, a modest increase in endogenous O2 levels elicits sub-
stantial enzymatic and growth defects in bacteria [45]. Despite the
remarkable antimicrobial potency of exogenous oxidants, Mtb seems
to express several mechanisms speciﬁcally directed to dissipate host-
generated oxidative stress for persistence in vivo. WhileMtb's ability to
resist host-generated redox stress is widely studied, to the best of our
knowledge how mycobacteria respond to a speciﬁc increase in
endogenous O2 level has not been characterized to date. Conse-
quently, we have developed a series of cell-permeable redox-cycling
drugs which generate ROS, speciﬁcally O2 via undergoing bioreduc-
tive activation inside mycobacteria. Because O2 is a charged species
at physiological pH (pKa¼4.8), it cannot penetrate cellular membranes
[27]. Keeping this in mind, ATD compounds were speciﬁcally designed
to generate O2 inside a mycobacterial cell. The speciﬁc detection of
O2 in the cytoplasm of mycobacteria validates our chemical synthesis
approach and indicates amechanism involving abstraction of electrons
from low-potential metal centers (Fe–S clusters), respiratory quinones,
and ﬂavins followed by univalent reduction of O2 to generate O2 by
ROS generators. Our results demonstrating exceptional sensitivity of
Mtb (including MDR/XDR strains) to compounds that generate endo-
genous ROS, along with the reported resistance of Mtb toward
exogenous oxidants, revealed crucial differences in defense mechan-
isms exploited by Mtb to tolerate ROS produced inside or outside the
bacterial cell. Such disparate responses to ROS were not observed in
other bacterial systems. For example, while under normal respiratory
conditions basal scavenging enzymes (e.g., Sod, Kat) are sufﬁcient to
protect E. coli from endogenous O2 and H2O2, any abnormal increase
in endogenous ROS levels by exogenous oxidative stress agents or
redox-cycling drugs is rapidly sensed by OxyR and SoxRS systems,
respectively, to mount an effective antioxidant response [46,47].
Interestingly, major antioxidant enzymatic systems in Mtb are either
secretory (SodA, KatG) or located in the periplasm (SodC), indicating
that the pathogen is evolutionarily equipped to neutralize extracellular
O2 derived from phagocytes during infection. The above ﬁndings,
along with the lack of a functional cytosolic redox-sensing system such
as OxyR or SoxR, indicate thatMtb is genetically programmed to divert
the majority of cellular antioxidant machinery to mitigate exogenous
ROS and to maintain cytoplasmic redox balance. While important in
the natural context of infection, these studies indicate that Mtb might
be vulnerable to redox-cycling drugs that permeate inside bacteria to
speciﬁcally elevate endogenous ROS levels and perturb redox home-
ostasis. Consistent with this, virulent H37Rv and MDR/XDR strains
have shown exceptional sensitivity to an increase in endogenous ROS/
RNS by redox-cycling drugs such as nitroimidazopyrans, CFZ, and
vitamin C [12,27,44]. In contrast, other bacterial species (including
Msm) known to contain nonsecretory forms of antioxidant enzymes
and capable of inducing an OxyR-type protective oxidative stress
response were comparatively more tolerant to killing by nitroimida-
zopyrans, vitamin C, and ATD compounds (Table 1) [35,48].
The production of millimolar concentrations of cytoplasmic redox
buffer, MSH, is the main mechanism by whichmycobacteria maintain
a reduced cytosolic state [49]. We reasoned that if ATD-3169
speciﬁcally elevates endogenous ROS levels, then one would expect
to observe perturbation of mycothiol redox homeostasis in Mtb.
Using a novel mycothiol biosensor [14], we showed that ATD-3169
induces a rapid and long-lasting oxidative shift in EMSH of Mtb,
indicating impairment of MSH-controlled reductive capabilities of
Mtb by ATD-3169. A similar oxidative shift in EMSH was induced in
MDR/XDR strains, raising an interesting possibility of targeting
mycothiol redox pathway to impact survival of both drug-sensitive
and drug-tolerant Mtb strains. The importance of the mycothiol
pathway in tolerating endogenous ROS is further revealed by our
ﬁndings showing an exceptionally high sensitivity of MtbΔmshA
toward ATD-3169. The reported higher antioxidant capacity of Msm
(EMSH¼-300 mV) as compared to Mtb (EMSH¼270 mV) may have
partly contributed to differential susceptibility of these strains toward
ATD-3169 in our study [14]. Finally, our microarray data validate our
estimates that ATD-3169 induces endogenous oxidative stress and
perturbs mycobacterial redox metabolism. Similar to other redox-
cycling drugs, ATD-3169 appears to function by disrupting iron
homeostasis. Induction of genes encoding the Fe–S cluster containing
TCA cycle enzymes, iron-storage proteins, Fe–S cluster repair pro-
teins, and iron repressors clearly indicates elevated iron levels due to
damage of Fe–S clusters by ATD-3169. Because iron is the coreactant
in the Fenton reaction, which increased the chances of DNA damage,
a large number of DNA repair genes were upregulated. Interestingly,
we also observed activation of the gluconeogenesis pathway and
drug-efﬂux pumps in response to ATD-3169. Since NADPH depletion
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is a most likely a consequence of redox cycling, it is possible that
induction of genes involved in gluconeogenesis may be a mechanism
to restore cellular NADPH levels. Similarly, upregulation of drug-
efﬂux pumps is one of the predominant strategies exploited by
bacteria to excrete redox-cycling drugs. Of note, the drug-efﬂux
pumps induced by ATD-3169 were similarly regulated in response
to a macrophage environment, anti-TB drugs, and redox agents,
indicating their broader role in detoxiﬁcation and maintaining
cellular homeostasis [50,51]. While induction of many oxidative
stress responsive genes was clearly evident, expression of sodA,
ERG, and MSH biosynthetic genes was not affected on ATD-3169
treatment. Although unexpected, other expression studies have
shown that many antioxidant systems including SOD are constitu-
tively overexpressed in Mtb and that their expression remained
uninﬂuenced in response to an oxidative or nitrosative insult
[34,52]. Alternatively, it is likely that some posttranscriptional
mechanisms are involved in regulating the levels of these antiox-
idants in Mtb. For example, levels of SodA are directly modulated by
the activity of SecA2 secretion system in Mtb [53]. Similarly levels of
ERG can be regulated by the transport system(s) involved in its
secretion [54]. Lastly, changes in metabolite levels can alter levels of
MSH. Since cysteine and methionine biosynthetic genes are differ-
entially expressed in response to ATD-3169, MSH levels can be
regulated by changes in the ﬂux of cysteine or methionine on
oxidative stress. Interestingly, homologues of many ATD-3169-
inducible genes were similarly regulated by O2 and H2O2 in a
SoxR- and/or OxyR-dependent manner in other bacteria, indicating
the existence of novel redox-sensitive transcription factors in Mtb. In
this context, some of the members of the Mtb whiB family (Fe–S
cluster containing redox-sensitive transcription factors) appear to
modulate the oxidative stress response in Mtb [55,56].
In summary, our biochemical, genetic, and expression experiments
indicate that ATD-3169 enhances intramycobacterial ROS levels that
trigger bactericidal activity by weakening redox homeostasis in Mtb.
Due to the pressing need for developing novel interventional meth-
odologies to counterMtb, the effects of directly increasing endogenous
ROS, in real time, on the intracellular redox potential of Mtb and its
effects on mycobacterial physiology and survival were studied. We
ﬁnd that Mtb is uniquely sensitive to perturbation in redox home-
ostasis when it encounters elevated ROS within cells. Mtb secretes
large amounts of major antioxidant enzymes such as catalase and
superoxide dismutase to mitigate ROS encountered inside host
phagocytes. Impaired survival of Mtb strains lacking either secretory
antioxidants or major cell wall lipids in animal models of experimental
tuberculosis further emphasizes the importance of mechanisms to
alleviate toxicity associated with exogenous oxidants generated during
infection. The evolutionary role of effectively countering exogenous
ROS appears to have compromised Mtb's ability to overcome endo-
genous ROS. We anticipate that our ﬁndings will play an important
role in high content screening of small-molecule inhibitors of intra-
bacterial redox homeostasis and in delineating novel redox pathways
involved in persistence, drug resistance, and pathogenesis of Mtb.
Increased sensitivity displayed by Mtb toward elevated endogenous
ROS may be relevant to other intracellular pathogens (e.g., Salmonella
and Meningococcus) which mainly exploit secretory antioxidant
enzymes/systems to effectively divert exogenous superoxide during
infection. Thus, our ﬁndings may have relevance to several intracel-
lular pathogens causing chronic and relapsing infections where
persistence and drug tolerance pose challenges for treatment.
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